<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://californiabiotechlaw.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.7" --><!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.1.4" --><!-- generated-on="March 24, 2010 12:52 pm" --><!-- Debug: Total comment count: 34 --><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://californiabiotechlaw.com/</loc>
		<lastmod>2010-03-24T19:51:42+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings --><!-- Debug: Priority report of postID 894: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/fourteen-states-launch-constitutional-challenge-to-health-care-reform-bill/</loc>
		<lastmod>2010-03-24T19:51:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 881: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/biotech-industry-evaluates-anticipated-impact-of-health-care-reform/</loc>
		<lastmod>2010-03-22T22:46:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 877: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/california-biotech-law-blog-named-to-list-of-top-50-biotech-blogs/</loc>
		<lastmod>2010-03-04T03:42:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 870: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/carl-icahn-makes-move-to-raid-genzyme-board/</loc>
		<lastmod>2010-03-04T02:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 859: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/thescitechlawyer-profiles-california-biotech-law-blogs-kristie-prinz/</loc>
		<lastmod>2010-02-19T23:05:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 855: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/patrick-reilly-of-ip-society-interviews-california-biotech-law-blogs-kristie-prinz/</loc>
		<lastmod>2010-02-18T00:42:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 851: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/kristie-prinz-interviewed-by-technology-transfer-tactics-on-issue-of-whether-poster-presentations-jeopardize-a-ttos-commercialization-efforts/</loc>
		<lastmod>2010-02-13T02:09:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 844: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/seventh-circuit-rules-in-favor-of-warf-in-licensing-dispute-with-xenon-pharmaceuticals-case/</loc>
		<lastmod>2010-01-15T03:39:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 840: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/sbir-reauthorization-effort-continues-to-be-at-standstill/</loc>
		<lastmod>2010-01-13T03:05:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/advertising/</loc>
		<lastmod>2009-08-12T06:38:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 835: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/events/what-small-businesses-need-to-know-to-protect-their-companies-intellectual-property-assets/</loc>
		<lastmod>2009-08-12T06:14:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 825: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/events/what-companies-need-to-know-about-the-legal-risks-of-business-blogging/</loc>
		<lastmod>2009-08-12T06:10:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 828: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/events/secrets-to-launching-an-effective-blog-to-promote-your-business/</loc>
		<lastmod>2009-08-12T06:10:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 426: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/california-biotech-companies-rally-behind-proposed-new-tax-legislation/</loc>
		<lastmod>2009-08-11T22:50:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 513: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/two-dna-testing-companies-set-to-resume-business-in-the-bay-area/</loc>
		<lastmod>2009-08-07T02:09:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 516: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/genentech-launches-employee-retention-program/</loc>
		<lastmod>2009-08-07T02:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 521: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/status-of-sbir-reauthorization-unclear/</loc>
		<lastmod>2009-08-07T02:08:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 522: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/both-roche-and-genentech-remain-silent-on-status-of-acquisition-talks/</loc>
		<lastmod>2009-08-07T02:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 524: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/genentech-investments-affected-by-down-market/</loc>
		<lastmod>2009-08-07T02:07:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 530: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/sbirsttr-program-set-to-expire-later-this-month-support-for-reauthorization-waning/</loc>
		<lastmod>2009-08-07T02:06:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 532: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/roche-reported-to-be-close-to-deal-in-genentech-acquisition/</loc>
		<lastmod>2009-08-07T02:06:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 533: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/genentech-and-roche-agree-on-acquisition-deal-employees-end-up-as-big-winners/</loc>
		<lastmod>2009-08-07T02:05:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 535: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/congress-reaches-compromise-to-extend-sbir/</loc>
		<lastmod>2009-08-07T02:05:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 538: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/patent-reform-debate-revived-in-congress/</loc>
		<lastmod>2009-08-07T02:04:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 539: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/genetic-engineering-biotechology-news-interviews-kristie-prinz/</loc>
		<lastmod>2009-08-07T02:03:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/legal-services/</loc>
		<lastmod>2009-07-31T21:59:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/terms-and-conditions/</loc>
		<lastmod>2009-07-31T19:17:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 428: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/strategy-examined-on-how-patent-holders-are-delaying-market-entrance-by-generics/</loc>
		<lastmod>2009-07-31T01:26:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 340: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/victory-for-stem-cell-research-in-california/</loc>
		<lastmod>2009-07-31T01:21:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/contact-us/contact-kristie/</loc>
		<lastmod>2009-07-31T01:16:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 429: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/california-stem-cell-agency-funds-controlled-by-conflicts-of-interest/</loc>
		<lastmod>2009-07-31T01:15:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 430: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/house-declines-to-address-generics-provisions-of-fda-legislation/</loc>
		<lastmod>2009-07-31T01:14:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 431: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/viacell-wins-infringement-suit-over-pharmastem/</loc>
		<lastmod>2009-07-31T01:12:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 434: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/case-study-for-potential-impact-of-new-generics-legislation/</loc>
		<lastmod>2009-07-31T01:07:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 437: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/court-ruling-denies-terminally-ill-patients-the-right-to-unapproved-but-potentially-life-saving-drugs/</loc>
		<lastmod>2009-07-31T01:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 439: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/californias-stem-cell-priorities-is-the-state-ahead-of-its-time-or-was-the-vote-a-reactionary-political-decision/</loc>
		<lastmod>2009-07-31T01:04:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 440: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/genzymes-example-of-myozyme-a-case-study-for-why-biogenerics-legislation-is-a-bad-idea/</loc>
		<lastmod>2009-07-31T01:03:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 441: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/biotech-takes-steps-to-fight-generic-threat/</loc>
		<lastmod>2009-07-31T01:02:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 445: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/congress-to-consider-sbir-funding-increase/</loc>
		<lastmod>2009-07-31T00:59:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 447: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/kristie-prinz-interview-with-dow-jones-marketwatch-on-patent-holding-companies-patent-reform/</loc>
		<lastmod>2009-07-31T00:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 449: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/biogenerics-legislation-to-be-tabled-in-2007/</loc>
		<lastmod>2009-07-31T00:56:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 456: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/fda-to-colloborate-with-congress-on-developing-follow-on-biologics-legislation/</loc>
		<lastmod>2009-07-31T00:54:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 501: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/pharmaceutical-companies-taking-steps-to-comply-with-new-regulations/</loc>
		<lastmod>2009-07-31T00:53:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 523: Comments: 2 of 34 = 0.1 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/practical-tips/irs-taking-closer-look-at-tech-transfer-offices-activities/</loc>
		<lastmod>2009-07-31T00:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 529: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/silicon-valley-ip-licensing-law-blog/</loc>
		<lastmod>2009-07-31T00:50:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 536: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/biosimilars-legislation-introduced-in-house/</loc>
		<lastmod>2009-07-31T00:48:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/privacy-policy/</loc>
		<lastmod>2009-07-31T00:41:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 382: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/uspto-rejects-warf-stem-cell-patent-claims-on-re-examination/</loc>
		<lastmod>2009-07-30T01:01:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 462: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/uspto-upholds-warf-stem-cell-patent-claim/</loc>
		<lastmod>2009-07-30T01:01:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 474: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/gilead-sciences-overtakes-amgen-as-worlds-second-most-highly-valued-biotech/</loc>
		<lastmod>2009-07-30T00:59:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 500: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/chinese-patent-system-problems-and-best-practices/</loc>
		<lastmod>2009-07-29T21:52:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 712: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/practical-tips/which-universities-have-the-most-successful-tech-transfer-programs-2/</loc>
		<lastmod>2009-07-29T21:49:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 458: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/more-evidence-that-outsourcing-is-on-the-rise-in-biotech-industry/</loc>
		<lastmod>2009-07-29T21:45:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 459: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/ftc-case-to-test-legality-of-pay-for-delay-settlements/</loc>
		<lastmod>2009-07-29T21:45:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 494: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/presidential-politics-more-on-the-mccain-healthcare-reform-plan/</loc>
		<lastmod>2009-07-29T21:44:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 507: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/dna-testing-companies-pulling-out-of-california-direct-to-consumer-market/</loc>
		<lastmod>2009-07-29T21:43:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 508: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/life-sciences-companies-spent-record-amount-on-lobbying-efforts-in-2007/</loc>
		<lastmod>2009-07-29T21:43:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 54: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/patent-reform-legislation/</loc>
		<lastmod>2009-07-29T21:40:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 448: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/patent-reform-bill-passed-in-house/</loc>
		<lastmod>2009-07-29T21:36:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 455: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/stem-cell-research-in-california-providing-a-lesson-for-other-states/</loc>
		<lastmod>2009-07-29T21:35:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 40: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/brand-generics-debate/</loc>
		<lastmod>2009-07-29T21:29:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 433: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/uspto-to-reconsider-patents-on-hiv-drug-viread/</loc>
		<lastmod>2009-07-29T21:28:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 61: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/gilead-sciences-resolves-dispute-with-roche/</loc>
		<lastmod>2009-07-29T21:17:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 515: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/former-city-of-hope-inventor-files-suit-to-collect-back-royalties/</loc>
		<lastmod>2009-07-29T21:15:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 452: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/pfizer-to-discontinue-sales-of-inhaled-insulin-drug-exubera/</loc>
		<lastmod>2009-07-29T21:13:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 83: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/american-pharmaceutial-to-acquire-santa-monica-based-american-bioscience/</loc>
		<lastmod>2009-07-29T21:11:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 509: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/roche-makes-437-billion-bid-to-acquire-genentech/</loc>
		<lastmod>2009-07-29T21:01:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/about-us/</loc>
		<lastmod>2009-07-29T17:58:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 29: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotechnology-law-2005-2/</loc>
		<lastmod>2009-07-29T00:55:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 67: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/international-symposium-on-stem-cell-collaboration/</loc>
		<lastmod>2009-07-29T00:55:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 45: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioscience-forum-3/</loc>
		<lastmod>2009-07-29T00:55:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 47: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/patenting-of-life-forms-2/</loc>
		<lastmod>2009-07-29T00:55:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 48: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/california-healthcare-policy-forum-2/</loc>
		<lastmod>2009-07-29T00:55:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 84: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/san-diego-based-ambrx-to-collaborate-with-roche/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 87: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/les-technology-transfer-seminar-2/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 205: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-bios-meet-your-candidate-fiona-ma-2/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 188: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/tech-depot-lunch-and-learn/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 101: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/healthcarebio-science-summit-spring-venture-forum-new-frontiers-in-medicine/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 170: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-area-biotech-faster-cheaper-and-better-the-future-of-drug-development-2/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 141: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/opening-statements-in-stem-cell-case-set-to-begin/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 204: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/fifth-annual-bioe2e-alternative-funding-fair/</loc>
		<lastmod>2009-07-29T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 207: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-stem-cell-meeting-on-the-mesa-2/</loc>
		<lastmod>2009-07-29T00:55:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 242: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/workitcoms-third-annual-networking-event/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 240: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/deep-ocean-bacteria-as-a-new-resource-for-antibiotic-drug-discovery-2/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 239: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/microarray-technologie-2/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 230: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/simon-ramo-distinguished-lecture-the-changing-pharmaceutical-industry-2/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 219: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/connecting-people-to-company-success/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 241: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioprocess-international-conference-exhibition/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 273: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/san-diego-biotech-discussion-group-2/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 274: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/discovering-the-next-frontier-of-green-technology-2/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 275: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/discovering-the-next-frontier-of-green-technology/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 276: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/evidence-economics-and-politics-australias-experiment-in-evidence-based-medicine/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 249: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/working-together/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 253: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-stakes-get-higher-the-impact-of-the-schering-oig-settlement-and-gleason-indictment-on-drug-promotion/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 259: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioe2es-fourth-annual-pitch-event/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 277: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/technology-leadership-evangelism-in-the/</loc>
		<lastmod>2009-07-29T00:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 299: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-perils-and-opportunities-of-equity-comp-considering/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 283: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/dealing-with-darwin-how-great-companies-innovate-at-every-phase-of-their-evolution/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 300: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/licensing-what-you-need-to-know/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 302: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio-holiday-soiree-2006/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 279: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/navigating-the-patent-maze-inventorshipnotebooks/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 303: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/venture-capital-litigation-when-entrepreneurs-attack/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 291: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/recruiter-roundtable/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 285: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/how-to-sell-the-real-value-of-your-solution/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 297: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybioimpact-2007/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 290: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/growing-the-business-taking-sales-to-the-next-level/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 289: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/creating-a-worklife-balance/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 278: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/new-research-on-us-onshoring-nearshoring-on-global-it-labor-supply-trends-on-agile-methods-offshoring/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 298: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/corporate-governance-know-the-ground-avoid-the-potholes/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 286: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/demystifying-brand/</loc>
		<lastmod>2009-07-29T00:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 304: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/attracting-equity-investors-and-lessons-learned-mountain-view/</loc>
		<lastmod>2009-07-29T00:54:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 305: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/advisory-boards-increase-your-sales-and-profits-for-privately-held-and-family-owned-businesses/</loc>
		<lastmod>2009-07-29T00:54:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 379: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/sfawis-2007-april-networking-social-2/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 323: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/federal-circuit-judges-come-to-california-2/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 316: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/aaas-annual-meeting/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 321: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/chis-third-annual-biomarkers-in-preclinical-development-2/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 320: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/calculating-proving-patent-damages-conference-2/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 319: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-february-breakfast-meeting-2/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 308: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/nanobionexus-red-hot-holiday-party/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 307: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/attracting-equity-investors-and-lessons-learned-dublin/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 317: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/partnering-and-outsourcing-models-in-biology-and-preclinical-rd-2/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 331: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/building-a-successful-nanotech-company-what-will-it-take-in-todays-market/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 306: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/annual-holiday-party/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 318: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/research-expo-2/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 322: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio-advantage-molecular-medicine-tri-conference/</loc>
		<lastmod>2009-07-29T00:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 381: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/both-sides-of-biologics-debate-explored-in-marketplace-money-feature/</loc>
		<lastmod>2009-07-29T00:54:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 404: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioscience-forum-beta-amyloid-as-a-therapeutic-target-for-alzheimers-disease-where-are-we-after-twenty-years/</loc>
		<lastmod>2009-07-29T00:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 405: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocoms-monthly-breakfast-meetingprivate-equity-investing-and-alternative-financing-models/</loc>
		<lastmod>2009-07-29T00:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 389: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/uscd-extension-introduction-to-nanotechnology/</loc>
		<lastmod>2009-07-29T00:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 407: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/rx-drug-pricing-boot-camp/</loc>
		<lastmod>2009-07-29T00:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 406: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/how-to-prepare-a-budget-identifying-key-assumptions-statistical-inputs/</loc>
		<lastmod>2009-07-29T00:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 408: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-neurotechnology-industry-investing-and-partnering-conference/</loc>
		<lastmod>2009-07-29T00:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 427: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/the-latest-on-biotech-valuations/</loc>
		<lastmod>2009-07-29T00:54:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 425: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/new-challenge-to-the-biotech-industry/</loc>
		<lastmod>2009-07-29T00:54:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 442: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/fda-exercising-new-caution-in-approving-drugs/</loc>
		<lastmod>2009-07-29T00:54:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 486: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legal-disputes/us-supreme-court-postpones-decision-on-review-of-patent-rights-case-seeks-input-from-bush-administration/</loc>
		<lastmod>2009-07-29T00:52:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 463: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/new-bill-to-provide-biotech-companies-sarbanes-oxley-relief/</loc>
		<lastmod>2009-07-29T00:52:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 490: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/sbirsttr-reauthorization-act-passes-in-house-biotech-industry-is-big-winner/</loc>
		<lastmod>2009-07-29T00:52:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 526: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/biotech-industry-begins-to-assess-likely-impact-of-new-administration/</loc>
		<lastmod>2009-07-29T00:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 496: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/stemcells-files-infringement-suit-against-neuralstem-2/</loc>
		<lastmod>2009-07-29T00:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 498: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legal-disputes/dna-testing-should-private-companies-be-able-to-conduct-dna-tests-outside-without-physician-input/</loc>
		<lastmod>2009-07-29T00:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 499: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/congress-examining-uspto-backlog-issues/</loc>
		<lastmod>2009-07-29T00:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/newsletter/</loc>
		<lastmod>2009-07-16T19:54:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/contact-us/</loc>
		<lastmod>2009-07-02T19:43:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/about/info/</loc>
		<lastmod>2009-06-18T21:00:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://californiabiotechlaw.com/about/</loc>
		<lastmod>2009-06-18T19:30:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 537: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/federal-circuit-rules-on-case-involving-new-uspto-patent-rules/</loc>
		<lastmod>2009-03-23T23:24:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 534: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/gilead-sciences-to-buy-cv-therapeutics-for-14-billion/</loc>
		<lastmod>2009-03-16T00:53:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 528: Comments: 3 of 34 = 0.1 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/stem-cell-research-are-californias-priorities-in-the-right-place/</loc>
		<lastmod>2009-01-21T03:26:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 527: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/biotech-companies-filing-for-bankruptcy-in-bad-economy/</loc>
		<lastmod>2008-11-22T01:22:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 525: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/biotech-facing-a-long-ipo-dry-spell/</loc>
		<lastmod>2008-11-03T22:55:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 519: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/university-tech-transfer/which-universities-have-the-most-successful-tech-transfer-programs/</loc>
		<lastmod>2008-09-16T21:34:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 518: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/south-san-francisco-based-novacea-merges-with-transcept-pharmaceuticals/</loc>
		<lastmod>2008-09-05T23:45:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 517: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/report-raises-concerns-about-medical-identity-theft/</loc>
		<lastmod>2008-08-26T21:37:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 514: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/sba-seeking-comments-on-plans-to-raise-sbir-award/</loc>
		<lastmod>2008-08-21T19:38:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 512: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/senate-committee-passes-compromise-sbir-reauthorization-bill/</loc>
		<lastmod>2008-08-18T22:29:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 511: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/fallout-continues-on-roche-bid-for-genentech/</loc>
		<lastmod>2008-08-18T20:30:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 510: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/genentech-declines-roche-437-billion-acquisition-offer/</loc>
		<lastmod>2008-08-15T01:35:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 506: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/fallout-over-genetic-testing-controversy-continues/</loc>
		<lastmod>2008-06-19T06:29:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 505: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/california-takes-first-step-towards-regulating-genetic-testing-companies/</loc>
		<lastmod>2008-06-17T06:33:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 504: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/bristol-myers-squibb-to-acquire-kosan-biosciences-for-190-million/</loc>
		<lastmod>2008-06-01T01:25:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 503: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/medimmune-settles-dispute-with-genentech/</loc>
		<lastmod>2008-06-01T01:00:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 502: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/outlook-for-biotech-industry-mixed-in-2008/</loc>
		<lastmod>2008-05-25T03:09:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 497: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/stemcells-files-infringement-suit-against-neuralstem/</loc>
		<lastmod>2008-05-14T01:50:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 495: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/china-set-to-compete-in-generics-market/</loc>
		<lastmod>2008-05-13T23:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 492: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/us-supreme-court-petition-challenges-constitutionality-of-patent-appeals-judge-appointments/</loc>
		<lastmod>2008-04-29T01:13:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 491: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/senate-passes-legislation-banning-genetic-discrimination/</loc>
		<lastmod>2008-04-25T04:51:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 489: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/california-supreme-court-overturns-punitive-damage-award-against-genentech/</loc>
		<lastmod>2008-04-25T00:07:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 488: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/san-diego-consortium-for-regenerative-medicine-to-build-115-million-stem-cell-research-facility-in-san-diego/</loc>
		<lastmod>2008-04-23T00:56:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 487: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/biotech-companies-running-into-roadblocks-in-entering-into-deals-with-the-uc-system/</loc>
		<lastmod>2008-04-22T23:44:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 485: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/patent-reform-bill-stalled-in-senate/</loc>
		<lastmod>2008-04-18T21:19:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 483: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/takeda-acquires-millennium-pharmaceuticals-for-88-billion/</loc>
		<lastmod>2008-04-18T01:01:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 482: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/cv-therapeutics-signs-lucrative-deal-with-tpg-axon-capital/</loc>
		<lastmod>2008-04-17T23:27:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 481: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/billionaire-investor-carl-icahn-files-suit-against-biogen/</loc>
		<lastmod>2008-04-16T20:59:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 480: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legal-disputes/patent-office-to-consider-appeal-of-ruling-which-voided-patent-rule-changes/</loc>
		<lastmod>2008-04-16T18:36:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 479: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/bio-spent-66-million-on-lobbying-efforts-in-2007/</loc>
		<lastmod>2008-04-08T23:19:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 478: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/doctor-conflicts-should-the-public-be-concerned-about-bias-against-the-drug-companies-rather-than-just-the-possibility-of-bias-in-favor-of-drug-companies/</loc>
		<lastmod>2008-04-03T02:01:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 477: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/cell-genesys-closes-320-million-deal-with-takeda/</loc>
		<lastmod>2008-04-03T00:50:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 476: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/house-committee-holds-hearing-to-consider-modernizing-sbir-program/</loc>
		<lastmod>2008-04-01T01:39:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 475: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/vaxgen-terminates-merger-agreement-liquidation-may-follow/</loc>
		<lastmod>2008-03-31T21:41:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 473: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legal-disputes/canadian-drug-company-biovail-settles-sec-accounting-fraud-charges/</loc>
		<lastmod>2008-03-28T16:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 472: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/are-rushed-approvals-by-the-fda-responsible-for-recent-rash-of-drug-problems/</loc>
		<lastmod>2008-03-27T18:02:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 471: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/do-investors-dislike-biotech-alliances/</loc>
		<lastmod>2008-03-27T15:52:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 470: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legal-disputes/class-action-suit-to-test-whether-drug-companies-have-legal-duty-to-class-members-for-money-spent-on-off-label-uses-of-generic/</loc>
		<lastmod>2008-03-26T18:52:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 469: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/congress-to-consider-legislation-requiring-doctor-disclosure-of-gifts-received-from-drug-companies/</loc>
		<lastmod>2008-03-21T19:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 468: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/california-files-suit-against-abbott-laboratories-for-scheme-to-block-generic/</loc>
		<lastmod>2008-03-21T01:26:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 467: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/fraud-charges-filed-against-former-intermune-ceo/</loc>
		<lastmod>2008-03-21T00:09:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 466: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/update-on-the-implementation-of-new-legislation-to-expand-federal-clinical-trial-disclosure-laws/</loc>
		<lastmod>2008-03-19T00:35:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 465: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/uspto-proposes-rule-change-to-require-biological-deposits/</loc>
		<lastmod>2008-03-06T15:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 464: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/presidential-politics-what-is-the-mccain-plan-for-healthcare-reform/</loc>
		<lastmod>2008-03-06T05:00:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 460: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/stem-cell-companies-looking-ahead-to-new-administration/</loc>
		<lastmod>2008-02-27T17:38:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 457: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/california-governor-views-californias-experience-with-stem-cell-research-as-providing-a-strong-example-for-other-states-to-follow/</loc>
		<lastmod>2008-02-12T23:59:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 454: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/debating-the-future-of-the-sbir-program/</loc>
		<lastmod>2008-02-05T03:18:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 453: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/supreme-court-declines-to-hear-case-on-experimental-drugs/</loc>
		<lastmod>2008-01-23T06:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 451: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/health-advocacy-and-medical-specialty-groups-lobby-congress-to-change-rules-on-sbir-eligibility/</loc>
		<lastmod>2007-10-19T06:18:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 450: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/federal-circuit-imposes-new-limits-on-willful-infringement/</loc>
		<lastmod>2007-09-15T00:15:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 436: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/stanford-uc-representatives-offer-insights-on-licensing-with-their-universities/</loc>
		<lastmod>2007-08-03T07:14:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 435: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/biotech-vs-high-tech-opposing-views-on-patent-reform/</loc>
		<lastmod>2007-07-24T08:23:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 802: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/biotech-exit-strategy-dependent-on-mergers-acquisitions-over-ipos-2/</loc>
		<lastmod>2007-07-17T05:16:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 432: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/biotech-exit-strategy-dependent-on-mergers-acquisitions-over-ipos/</loc>
		<lastmod>2007-07-17T05:16:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 424: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/california-stem-cell-institute-plan-revealed-on-distributing-the-research-money/</loc>
		<lastmod>2007-07-02T01:09:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 423: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/professor-predicts-biotechnology-will-have-key-role-in-future/</loc>
		<lastmod>2007-07-02T00:26:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 422: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/sky-radios-dennis-michael-interviews-kristie-prinz-on-biotech-industry-developments/</loc>
		<lastmod>2007-07-01T23:56:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 421: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/big-cap-biotech-stocks-taking-hit-on-wall-street/</loc>
		<lastmod>2007-07-01T23:23:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 420: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/senate-committee-approves-new-generics-legislation/</loc>
		<lastmod>2007-06-29T06:38:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 419: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/lexblog-interviews-california-biotech-law-blogs-kristie-prinz/</loc>
		<lastmod>2007-06-25T23:25:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 418: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/president-bush-vetoes-latest-stem-cell-bill/</loc>
		<lastmod>2007-06-21T07:02:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 417: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/california-healthcare-institute-warns-state-biotech-industry-at-risk/</loc>
		<lastmod>2007-06-19T05:55:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 416: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/another-look-at-medimmune-v-genentech/</loc>
		<lastmod>2007-05-30T07:41:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 415: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/another-new-investor-jumps-on-the-biotech-bandwagon/</loc>
		<lastmod>2007-05-29T06:49:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 414: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/key-issues-to-consider-in-biotech-licensing/</loc>
		<lastmod>2007-05-29T06:10:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 413: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/new-report-says-outsourcing-on-the-rise-in-the-life-sciences-industry/</loc>
		<lastmod>2007-05-23T23:48:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 412: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/googles-new-interest-in-biotech/</loc>
		<lastmod>2007-05-23T22:51:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 411: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/industry-group-sends-letter-to-congress-on-patent-reform/</loc>
		<lastmod>2007-05-17T07:41:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 410: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/stem-cell-suits-dismissed-by-california-supreme-court/</loc>
		<lastmod>2007-05-17T06:37:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 409: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/new-study-urges-caution-in-anticipating-stem-cell-research-payoff/</loc>
		<lastmod>2007-05-16T06:35:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 403: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/european-federation-of-intellectual-property/</loc>
		<lastmod>2007-04-22T17:33:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 402: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/handling-intellectual-property-in-business-transactions/</loc>
		<lastmod>2007-04-18T07:53:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 401: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotechnology-law-roundtable-teleconference/</loc>
		<lastmod>2007-04-18T07:21:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 400: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/tech-transfer-office-culture-preventing-commercialization-of-technology/</loc>
		<lastmod>2007-04-17T08:04:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 399: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/senate-passes-stem-cell-funding-bill/</loc>
		<lastmod>2007-04-12T07:32:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 398: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/bay-area-venture-funded-life-science-companies-increase-valuations/</loc>
		<lastmod>2007-04-12T06:53:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 397: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/the-ethics-of-paying-to-continue-a-clinical-trial/</loc>
		<lastmod>2007-04-12T04:51:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 396: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/stem-cell-bills-set-to-be-debated-in-senate/</loc>
		<lastmod>2007-04-10T06:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 395: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/april-breakfast-meeting-hrx-for-success-strategies-every-life-science-leader-should-know-to-increase-company-performance/</loc>
		<lastmod>2007-04-09T03:20:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 801: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/nanobionexus-patenting-licensing-nanotechnology-where-much-can-go-wrong-if-you-dont-get-it-right-2/</loc>
		<lastmod>2007-04-09T01:55:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 394: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/nanobionexus-patenting-licensing-nanotechnology-where-much-can-go-wrong-if-you-dont-get-it-right/</loc>
		<lastmod>2007-04-09T01:55:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 393: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio-2007/</loc>
		<lastmod>2007-04-09T01:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 392: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/is-an-ip-holding-company-still-just-a-troll-licensing-and-enforcement-strategies-for-ip-holding-companies-and-others/</loc>
		<lastmod>2007-04-09T01:49:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 391: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/life-sciences-law-institute/</loc>
		<lastmod>2007-04-09T01:25:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 390: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybionests-first-annual-partnering-event/</loc>
		<lastmod>2007-04-09T01:20:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 388: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/winning-product-submissions-find-out-what-the-fda-is-looking-for-how-to-get-your-product-approved-sooner/</loc>
		<lastmod>2007-04-09T00:53:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 800: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/winning-product-submissions-find-out-what-the-fda-is-looking-for-how-to-get-your-product-approved-sooner-2/</loc>
		<lastmod>2007-04-09T00:53:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 387: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/uc-berkeley-extention-the-drug-development-process/</loc>
		<lastmod>2007-04-09T00:05:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 386: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/les-technology-transfer-seminar/</loc>
		<lastmod>2007-04-08T23:49:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 799: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/gtcbios-enforcement-litigation-in-the-biotech-pharmaceutical-industry-2/</loc>
		<lastmod>2007-04-08T23:49:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 385: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/gtcbios-enforcement-litigation-in-the-biotech-pharmaceutical-industry/</loc>
		<lastmod>2007-04-08T23:49:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 384: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotech-demystified-the-science-behind-the-business/</loc>
		<lastmod>2007-04-08T23:31:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 383: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/tunnel-consulting-summit-bioprocessing-throughout-the-product-life-cycle/</loc>
		<lastmod>2007-04-08T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 380: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/community-based-approach-to-neglected-infectious-disease-research/</loc>
		<lastmod>2007-04-03T07:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 378: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/outsourcing-trends-in-the-biotech-industry/</loc>
		<lastmod>2007-04-02T16:48:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 377: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/clinical-quality-assurance-and-management-policy-two-case-histories/</loc>
		<lastmod>2007-04-02T08:18:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 376: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/entrepreneurship-and-building-a-sustainable-organization/</loc>
		<lastmod>2007-04-02T08:09:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 375: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ceosummit-2007-presents-from-startup-to-sustainablity/</loc>
		<lastmod>2007-04-02T07:51:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 374: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/third-annual-venture-capital-awards/</loc>
		<lastmod>2007-04-02T07:40:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 373: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/sfawis-2007-april-networking-social/</loc>
		<lastmod>2007-04-02T07:38:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 372: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/invitrogen-distinguished-lecture/</loc>
		<lastmod>2007-04-02T07:28:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 371: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ibfs-18th-annual-venture-capital-investing-conference/</loc>
		<lastmod>2007-04-02T07:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 370: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2007-deans-symposiumexploring-proteins/</loc>
		<lastmod>2007-04-02T06:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 369: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/11th-annual-life-science-live-at-the-opera/</loc>
		<lastmod>2007-04-02T06:40:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 368: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/french-american-biotech-connection/</loc>
		<lastmod>2007-04-02T06:32:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 367: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/licensing-when-what-where-how/</loc>
		<lastmod>2007-04-02T06:24:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 798: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/licensing-when-what-where-how-2/</loc>
		<lastmod>2007-04-02T06:24:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 366: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocoms-legislative-roundtable-with-congressman-bob-filner/</loc>
		<lastmod>2007-04-02T06:15:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 365: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/bay-area-blawgers-event-re-cap/</loc>
		<lastmod>2007-03-30T03:58:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 364: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/five-biotech-companies-to-watch/</loc>
		<lastmod>2007-03-30T02:12:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 363: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/top-five-regions-targeting-biotech-companies/</loc>
		<lastmod>2007-03-28T07:53:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 362: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/new-biotech-trend-private-equity-investing/</loc>
		<lastmod>2007-03-27T06:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 361: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/bill-proposed-to-establish-california-office-of-intellectual-property/</loc>
		<lastmod>2007-03-27T05:25:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 360: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/hr-1561the-enhancing-drug-safety-and-innovation-act-of-2007/</loc>
		<lastmod>2007-03-23T06:19:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 359: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/angel-investing-reported-to-be-up-in-2007/</loc>
		<lastmod>2007-03-23T05:35:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 358: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-bio-member-orientation/</loc>
		<lastmod>2007-03-23T00:33:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 357: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biobasics-briefing-2/</loc>
		<lastmod>2007-03-23T00:09:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 356: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/case-for-patent-reform/</loc>
		<lastmod>2007-03-15T16:53:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 355: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/affymetrix-wins-verdict-against-illumina/</loc>
		<lastmod>2007-03-15T07:44:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 354: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-area-blawgers-roundtable/</loc>
		<lastmod>2007-03-15T06:58:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 353: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/california-life-sciences-day/</loc>
		<lastmod>2007-03-08T08:00:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 352: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio-sacramento-office-grand-opening-reception/</loc>
		<lastmod>2007-03-08T08:00:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 351: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/oracle-life-sciences-community-day/</loc>
		<lastmod>2007-03-08T08:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 350: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/webinar-hiring-a-clinical-research-associate-what-you-dont-know-can-hurt-you/</loc>
		<lastmod>2007-03-08T07:23:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 349: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/fountainblues-life-science-entrepreneurs-forum-on-positioning-your-life-science-company-for-outside-funding/</loc>
		<lastmod>2007-03-08T07:15:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 348: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-legislative-round-table-with-assembly-member-joel-anderson/</loc>
		<lastmod>2007-03-08T07:06:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 347: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/myelin-repair-foundation-revolutionizing-medical-research/</loc>
		<lastmod>2007-03-08T06:55:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 346: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/sfawis-march-networking-social/</loc>
		<lastmod>2007-03-08T06:43:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 345: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/fourth-annual-counseling-workshop-for-careers-in-biotechnology-and-medical-devices/</loc>
		<lastmod>2007-03-08T06:34:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 344: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/second-annual-stem-cell-meeting/</loc>
		<lastmod>2007-03-08T06:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 343: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/clinical-trials-essentials-an-intensive-course/</loc>
		<lastmod>2007-03-08T06:10:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 797: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/startup-u-sfo-building-a-clear-significant-product-roadmap-with-eric-walcyzkowski-2/</loc>
		<lastmod>2007-03-08T05:44:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 342: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/startup-u-sfo-building-a-clear-significant-product-roadmap-with-eric-walcyzkowski/</loc>
		<lastmod>2007-03-08T05:44:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 341: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/nanotechnology-in-drug-delivery-how-close-are-we/</loc>
		<lastmod>2007-03-08T05:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 339: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/biotech-companies-testing-the-open-source-model/</loc>
		<lastmod>2007-02-23T06:49:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 338: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/biotechnology-and-the-law/</loc>
		<lastmod>2007-02-22T02:15:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 337: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/genentech-claims-rejected-on-patent-which-was-subject-of-recent-supreme-court-decision/</loc>
		<lastmod>2007-02-21T23:33:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 336: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/potential-impact-of-new-generics-bill/</loc>
		<lastmod>2007-02-21T06:27:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 335: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/new-victory-for-stem-cell-research/</loc>
		<lastmod>2007-02-17T06:16:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 334: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/calbioannual-dinner-2007/</loc>
		<lastmod>2007-01-16T03:14:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 333: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-2nd-annual-california-life-science-career-fair/</loc>
		<lastmod>2007-01-16T03:12:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 332: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ibcs-18th-international-antibody-development-production-successful-upstream-and-downstream-processing-approaches/</loc>
		<lastmod>2006-12-13T23:30:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 796: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ibcs-18th-international-antibody-development-production-successful-upstream-and-downstream-processing-approaches-2/</loc>
		<lastmod>2006-12-13T23:30:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 330: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/federal-circuit-judges-come-to-california/</loc>
		<lastmod>2006-12-13T03:10:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 329: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio-advantage/</loc>
		<lastmod>2006-12-13T03:08:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 328: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/chis-third-annual-biomarkers-in-preclinical-development/</loc>
		<lastmod>2006-12-13T03:07:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 795: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/calculating-proving-patent-damages-conference-3/</loc>
		<lastmod>2006-12-13T03:05:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 327: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/calculating-proving-patent-damages-conference/</loc>
		<lastmod>2006-12-13T03:05:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 326: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-february-breakfast-meeting/</loc>
		<lastmod>2006-12-13T03:02:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 325: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/research-expo/</loc>
		<lastmod>2006-12-13T03:00:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 324: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/partnering-and-outsourcing-models-in-biology-and-preclinical-rd/</loc>
		<lastmod>2006-12-13T02:59:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 794: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/partnering-and-outsourcing-models-in-biology-and-preclinical-rd-3/</loc>
		<lastmod>2006-12-13T02:59:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 793: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/calculating-proving-patent-damages-conference-2-2/</loc>
		<lastmod>2006-12-13T00:32:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 792: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/partnering-and-outsourcing-models-in-biology-and-preclinical-rd-2-2/</loc>
		<lastmod>2006-12-13T00:21:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 315: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/business-to-business-networking-extravaganza/</loc>
		<lastmod>2006-12-12T04:25:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 314: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/law-seminars-international-presents-biotechnology-2007/</loc>
		<lastmod>2006-12-12T04:23:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 313: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/high-content-analysis-2007/</loc>
		<lastmod>2006-12-12T04:21:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 312: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/advances-in-protein-crystallography-conference-and-exhibition/</loc>
		<lastmod>2006-12-12T04:18:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 311: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-january-breakfast-meeting/</loc>
		<lastmod>2006-12-12T04:16:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 310: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/idea-to-ipoand-beyond/</loc>
		<lastmod>2006-12-12T04:16:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 309: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-area-health-care-breakfast-club-breakfast-with-david-druker-md/</loc>
		<lastmod>2006-12-12T04:14:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 301: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/kurisu-forum-san-diego-forum-and-holiday-brunch/</loc>
		<lastmod>2006-12-05T22:18:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 296: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ucsd-extension-biomedical-product-development/</loc>
		<lastmod>2006-12-04T23:26:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 295: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/medicinal-chemistry-online-certificate-program/</loc>
		<lastmod>2006-12-04T23:25:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 294: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-international-conference-bio-and-pharmaceutical-science-and-technology-and-bio-and-pharmaceutical-technology-exhibition/</loc>
		<lastmod>2006-12-04T23:22:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 293: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-year-in-perspective/</loc>
		<lastmod>2006-12-04T23:20:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 292: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/adverse-event-reporting-in-clinical-trials-how-to-minimize-your-liability-by-working-with-investigators/</loc>
		<lastmod>2006-12-04T23:19:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 288: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/holiday-breakfast-event-with-comedian-will-durst/</loc>
		<lastmod>2006-12-04T23:11:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 287: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ispe-dinner-meeting-small-molecule-design/</loc>
		<lastmod>2006-12-04T23:11:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 284: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/third-annual-holiday-reception-licensing-executives-society-silicon-valley-chapter-and-women-in-licensingbay-area/</loc>
		<lastmod>2006-12-04T23:06:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 282: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/qb3ge-class-separation-and-purification-strategies-for-biotechnology-products/</loc>
		<lastmod>2006-12-04T23:03:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 281: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-paradox-of-excellence-2/</loc>
		<lastmod>2006-12-04T23:03:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 280: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bio-interface-2006/</loc>
		<lastmod>2006-12-04T23:03:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 791: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/new-research-on-us-onshoring-nearshoring-on-global-it-labor-supply-trends-on-agile-methods-offshoring-2/</loc>
		<lastmod>2006-12-04T22:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 790: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/technology-leadership-evangelism-in-the-2/</loc>
		<lastmod>2006-12-04T22:05:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 272: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/raptor-pharmaceutical-signs-license-agreement-with-washington-university/</loc>
		<lastmod>2006-11-07T07:54:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 271: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/applied-biosystems-agrees-to-collaborate-on-molecule-detection-device/</loc>
		<lastmod>2006-11-07T07:39:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 270: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio-holiday-soiree-for-the-life-science-community/</loc>
		<lastmod>2006-11-07T05:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 269: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biobasics-briefing/</loc>
		<lastmod>2006-11-07T05:53:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 268: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/wilbas-third-annual-holiday-party/</loc>
		<lastmod>2006-11-07T05:49:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 267: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-paradox-of-excellence/</loc>
		<lastmod>2006-11-07T05:47:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 266: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/vc-taskforce-elevator-pitch-roundtable/</loc>
		<lastmod>2006-11-07T05:44:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 265: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biointerface-2006/</loc>
		<lastmod>2006-11-07T05:37:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 264: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-womens-technology-cluster-presents-celebrating-the-entrepreneur/</loc>
		<lastmod>2006-11-07T05:32:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 263: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/understanding-the-challenges-of-the-changing-oncology-marketplace/</loc>
		<lastmod>2006-11-07T05:28:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 262: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/pg-open-meeting-and-holiday-party/</loc>
		<lastmod>2006-10-25T05:24:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 261: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/nanotechnology-in-cancer-research/</loc>
		<lastmod>2006-10-24T16:38:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 260: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/vwr-bdbioscience-lunch-and-learn-peptones-high-quality-supplements-for-biopharmaceutical-production/</loc>
		<lastmod>2006-10-24T05:20:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 258: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/peninsula-structures-focus-on-the-future/</loc>
		<lastmod>2006-10-24T05:12:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 257: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/labwize-best-practices-for-laboratory-design-2006/</loc>
		<lastmod>2006-10-24T05:08:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 256: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/new-directions-in-analgesic-drug-development/</loc>
		<lastmod>2006-10-24T05:01:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 255: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/san-diego-biocom-investor-conference/</loc>
		<lastmod>2006-10-24T04:58:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 254: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/life-science-facilities-decision-making-criteria-for-winning-proposals/</loc>
		<lastmod>2006-10-24T04:55:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 252: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2nd-annual-burrill-personalized-medicine-meeting-from-prediction-to-prevention/</loc>
		<lastmod>2006-10-24T04:37:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 251: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-global-bio-program-developing-the-future-leaders-of-bio/</loc>
		<lastmod>2006-10-24T04:32:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 250: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/working-togetherstrategies-for-a-successful-partnership/</loc>
		<lastmod>2006-10-22T16:41:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 248: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/animal-models-for-type-1-diabetes-and-multiple-sclerosis/</loc>
		<lastmod>2006-10-22T04:18:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 247: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/launch-silicon-valley/</loc>
		<lastmod>2006-10-22T04:15:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 246: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-november-breakfast-meeting-florida-friend-or-foe/</loc>
		<lastmod>2006-10-22T04:07:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 245: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/14th-annual-bio-investing-conference-rebuilding-the-pipeline/</loc>
		<lastmod>2006-10-21T16:48:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 244: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/connects-hall-of-fame-award-luncheon/</loc>
		<lastmod>2006-10-21T16:29:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 243: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/deep-ocean-bacteria-as-a-new-resource-for-antibiotic-drug-discovery/</loc>
		<lastmod>2006-10-20T16:24:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 789: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioprocess-international-conference-exhibition-2/</loc>
		<lastmod>2006-10-20T03:57:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 238: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/play-by-the-rules-equity-compensation-strategies-and-new-rules/</loc>
		<lastmod>2006-09-06T16:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 237: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-mitstanforduc-berkeley-nanotechnology-forum/</loc>
		<lastmod>2006-09-06T16:08:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 236: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/neuroinflammation-symposium/</loc>
		<lastmod>2006-09-06T16:08:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 235: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/first-annual-orange-county-medical-device-forum/</loc>
		<lastmod>2006-09-06T16:04:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 234: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/advanced-valuation-skills/</loc>
		<lastmod>2006-09-06T15:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 233: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/microarray-technologie/</loc>
		<lastmod>2006-09-06T15:38:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 232: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/oncology-leaders-forum-2006/</loc>
		<lastmod>2006-09-06T07:26:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 231: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/transition-to-industry-career-symposium/</loc>
		<lastmod>2006-09-06T07:01:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 229: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/new-and-emerging-causes-of-birth-defects-2/</loc>
		<lastmod>2006-09-05T10:42:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 226: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/is-clinical-trial-noncompliance-allowed-to-happen/</loc>
		<lastmod>2006-09-05T10:42:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 227: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-x-angel-funding/</loc>
		<lastmod>2006-09-05T10:42:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 228: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/new-and-emerging-causes-of-birth-defects/</loc>
		<lastmod>2006-09-05T10:42:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 225: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-401k-lunch-and-learn/</loc>
		<lastmod>2006-09-05T09:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 224: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-purchasing-event/</loc>
		<lastmod>2006-09-05T09:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 223: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-orange-county-cfo-breakfast/</loc>
		<lastmod>2006-09-05T09:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 222: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/simon-ramo-distinguished-lecture-the-changing-pharmaceutical-industry/</loc>
		<lastmod>2006-09-05T09:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 221: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/learning-consortium-project-management-that-works/</loc>
		<lastmod>2006-09-05T09:28:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 217: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/extraterritoriality-divided-claims-divided-lands/</loc>
		<lastmod>2006-09-05T09:28:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 218: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/hands-on-bioinformatics-computer-workshop/</loc>
		<lastmod>2006-09-05T09:28:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 220: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ip-transactional-intermediarieswho-are-they-and-what-do-they-do/</loc>
		<lastmod>2006-09-05T09:28:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 216: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/7th-annual-early-stage-investing-conference/</loc>
		<lastmod>2006-09-05T09:28:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 215: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/new-funding-opportunities-for-small-businesses/</loc>
		<lastmod>2006-09-05T09:28:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 788: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/3rd-global-pharma-rd-summit-2/</loc>
		<lastmod>2006-09-05T09:28:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 214: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/3rd-global-pharma-rd-summit/</loc>
		<lastmod>2006-09-05T09:28:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 213: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/8th-annual-nobel-science-and-appreciation-gala/</loc>
		<lastmod>2006-09-05T09:26:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 212: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-ix-term-sheet-negotiation/</loc>
		<lastmod>2006-09-05T07:18:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 211: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/womens-technology-cluster/</loc>
		<lastmod>2006-09-04T16:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 210: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/san-jose-biocenter/</loc>
		<lastmod>2006-09-04T16:32:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 209: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/biotech-watch/</loc>
		<lastmod>2006-09-04T16:28:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 208: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-stem-cell-meeting-on-the-mesa/</loc>
		<lastmod>2006-09-03T14:24:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 206: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotech-golf-network/</loc>
		<lastmod>2006-09-03T14:17:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 203: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-bios-meet-the-candidatejim-beall/</loc>
		<lastmod>2006-09-03T09:14:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 202: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/cio-institute/</loc>
		<lastmod>2006-09-03T09:14:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 200: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/qpcr-hands-on-training-program/</loc>
		<lastmod>2006-09-03T09:14:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 201: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-bio-investorforum/</loc>
		<lastmod>2006-09-03T09:14:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 199: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biosicence-forum-meeting-strategies-for-rapid-development-of-pharmaceutical-formulations/</loc>
		<lastmod>2006-09-03T09:14:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 198: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/managing-growth-while-maintaining-quality/</loc>
		<lastmod>2006-09-03T09:14:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 197: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/third-biennial-ucsd-innovators-showcase/</loc>
		<lastmod>2006-09-03T09:14:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 196: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-october-breakfast-meeting-talent-retention-strategies-that-work-industry-success-stories/</loc>
		<lastmod>2006-09-03T09:14:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 195: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/talent-retention-strategies-that-work-industry-success-stories/</loc>
		<lastmod>2006-09-03T09:14:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 194: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-bios-meet-your-candidate-fiona-ma/</loc>
		<lastmod>2006-09-03T09:13:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 192: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/sabpa-orange-countylos-angeles-life-sciences-conference/</loc>
		<lastmod>2006-09-03T09:13:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 193: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/cba-annual-conference-future-of-biotechnology-convergence-of-biology-and-engineering/</loc>
		<lastmod>2006-09-03T09:13:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 191: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-viii-due-diligence-process-and-package/</loc>
		<lastmod>2006-09-03T08:55:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 190: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-future-of-healthcare-investing-whats-hotwhats-not-in-biotech-medical-devices-and-healthcare-services/</loc>
		<lastmod>2006-09-03T08:53:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 189: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-purchasing-group-event/</loc>
		<lastmod>2006-09-03T08:53:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 187: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/licensing-executives-society-san-diego-chapter-business-aspects-of-regenerative-medicine/</loc>
		<lastmod>2006-09-03T08:53:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 186: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/meet-your-candidate/</loc>
		<lastmod>2006-09-03T08:53:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 185: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio-life-sciences-entrepreneur-and-investor-roundtable/</loc>
		<lastmod>2006-09-03T08:53:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 183: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/14th-annual-biopartnering-europe-investing-in-global-partnerships/</loc>
		<lastmod>2006-09-03T08:53:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 184: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioe2e-annual-funding-fair/</loc>
		<lastmod>2006-09-03T08:53:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 182: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/obtaining-orphan-drug-designation-in-europe/</loc>
		<lastmod>2006-09-03T08:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 181: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-vii-effective-investor-relations/</loc>
		<lastmod>2006-09-03T08:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 180: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biofocus/</loc>
		<lastmod>2006-09-03T08:45:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 179: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/san-diego-tech-transfer-forum/</loc>
		<lastmod>2006-09-03T08:45:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 178: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/frontiers-of-clinical-investigation-host-defense-2006-from-bench-to-bedside/</loc>
		<lastmod>2006-09-03T08:44:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 177: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-entrepreneur-venture-conference/</loc>
		<lastmod>2006-09-03T08:43:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 176: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/nyse-roundtable-the-future-of-the-biomedical-industry-in-an-era-of-globalization/</loc>
		<lastmod>2006-09-03T08:43:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 175: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/women-of-bioscience-happy-hour/</loc>
		<lastmod>2006-09-03T08:43:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 174: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bionetwork-2006/</loc>
		<lastmod>2006-09-03T08:40:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 173: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/financial-analysis-for-non-financial-executives-2/</loc>
		<lastmod>2006-09-03T08:40:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 172: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/financial-analysis-for-non-financial-executives/</loc>
		<lastmod>2006-09-03T08:38:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 171: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/innovations-in-light-microscopy/</loc>
		<lastmod>2006-09-03T08:38:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 169: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bay-area-biotech-faster-cheaper-and-better-the-future-of-drug-development/</loc>
		<lastmod>2006-09-03T08:38:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 168: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/premarket-approval-pma-and-510k-premarket-notification-workshop/</loc>
		<lastmod>2006-09-03T08:38:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 166: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-legislative-roundtable-2/</loc>
		<lastmod>2006-09-03T08:38:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 167: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/union-city-biotechnology-symposium/</loc>
		<lastmod>2006-09-03T08:38:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 165: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/annual-facilities-reception/</loc>
		<lastmod>2006-09-03T08:35:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 164: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioimmersion-biotech-for-non-scientists/</loc>
		<lastmod>2006-09-03T08:31:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 163: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/downstream-technology-forum-la-jolla/</loc>
		<lastmod>2006-09-03T08:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 162: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/connect-with-connect/</loc>
		<lastmod>2006-09-03T08:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 161: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/cima-at-berkeley-certified-investment-management-analyst/</loc>
		<lastmod>2006-09-03T08:31:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 160: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-v-owning-the-financials/</loc>
		<lastmod>2006-09-03T08:30:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 159: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/gene-acres-2006-building-successful-life-sciences-facilities/</loc>
		<lastmod>2006-09-03T08:20:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 158: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/some-revenue-and-tax-consequences-of-cross-border-patent-licensing-and-enforcement/</loc>
		<lastmod>2006-09-03T08:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 157: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-search-for-sustainable-predictable-growth/</loc>
		<lastmod>2006-09-03T08:00:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 787: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/intellectual-property-licensing-spin-outs-related-business-affairs-of-non-profit-organizations-2/</loc>
		<lastmod>2006-09-03T08:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 156: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/intellectual-property-licensing-spin-outs-related-business-affairs-of-non-profit-organizations/</loc>
		<lastmod>2006-09-03T08:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 155: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioscience-forum-2/</loc>
		<lastmod>2006-09-03T08:00:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 154: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-iv-positioning-science-in-a-commercial-context/</loc>
		<lastmod>2006-08-18T05:31:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 153: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/rnai-screening-on-the-mesa/</loc>
		<lastmod>2006-08-18T04:36:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 152: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-iii-patent-protectionip-strategy/</loc>
		<lastmod>2006-08-18T04:01:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 151: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bio-ceo-presentation-workshop/</loc>
		<lastmod>2006-08-17T23:01:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 150: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-bench-to-business-and-beyond/</loc>
		<lastmod>2006-08-17T07:59:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 149: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biobq/</loc>
		<lastmod>2006-08-17T07:59:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 148: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/creating-virtual-valuea-527-million-buyout-of-angiosyn-by-pfizer/</loc>
		<lastmod>2006-08-15T14:47:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 147: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-session-ii-business-strategies-that-attract-vcs/</loc>
		<lastmod>2006-07-03T03:31:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 146: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2006-womens-technology-cluster-catalyst-program-opening-night-reception/</loc>
		<lastmod>2006-07-02T03:05:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 145: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/report-on-bioscience-alliances-in-silicon-valley/</loc>
		<lastmod>2006-03-01T03:00:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 144: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/settlement-reached-in-university-of-california-case-against-monsanto/</loc>
		<lastmod>2006-02-28T14:11:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 143: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/stem-cell-plaintiffs-described-as-fumbling-on-first-day-of-trial/</loc>
		<lastmod>2006-02-28T11:56:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 142: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/biotech-response-to-proposed-uspto-changes/</loc>
		<lastmod>2006-02-27T15:56:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 140: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/intellectual-property-owners-association/</loc>
		<lastmod>2006-02-20T01:02:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 139: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioimmersion/</loc>
		<lastmod>2006-02-19T15:19:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 138: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-2006-venture-forum/</loc>
		<lastmod>2006-02-19T15:14:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 136: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/assay-development-high-throughput-screening/</loc>
		<lastmod>2006-02-19T14:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 137: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioscience-business-development-building-value/</loc>
		<lastmod>2006-02-19T14:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 786: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/assay-development-high-throughput-screening-2/</loc>
		<lastmod>2006-02-19T14:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 135: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/10th-annual-proteomics-conference-beyond-genome/</loc>
		<lastmod>2006-02-19T14:45:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 134: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybio2006-conference/</loc>
		<lastmod>2006-02-19T14:44:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 133: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/personalized-medicine-scientific-regulatory-and-business-dimensions/</loc>
		<lastmod>2006-02-19T14:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 132: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-june-breakfast/</loc>
		<lastmod>2006-02-19T08:55:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 131: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/introduction-to-fplc-theory-and-practice/</loc>
		<lastmod>2006-02-19T05:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 130: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/conducting-clinical-trials-abroad/</loc>
		<lastmod>2006-02-19T04:45:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-third-annual-bay-area-symposium-on-modulatory-small-rnas/</loc>
		<lastmod>2006-02-19T04:30:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 128: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-17th-annual-venture-capital-investing-conference/</loc>
		<lastmod>2006-02-19T03:10:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 127: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/from-idea-to-company-how-to-finance-structure-and-protect-your-fledgling-life-sciences-company/</loc>
		<lastmod>2006-02-19T02:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 126: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biomedical-workshops-for-engineersnon-biologists/</loc>
		<lastmod>2006-02-19T01:25:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 125: Comments: 1 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-news/biotech-valuations/</loc>
		<lastmod>2006-02-18T13:42:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 124: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/biotechnology-law-section-of-aba-science-and-technology-committee/</loc>
		<lastmod>2006-02-18T11:42:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 123: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/bioworld/</loc>
		<lastmod>2006-02-18T11:34:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 122: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/biocentury/</loc>
		<lastmod>2006-02-18T11:32:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 121: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/in-vivo/</loc>
		<lastmod>2006-02-18T11:31:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 120: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/start-up/</loc>
		<lastmod>2006-02-18T11:30:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 119: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/venture-capital-executive-program-elective-on-the-vc-firm/</loc>
		<lastmod>2006-02-18T06:42:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 118: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/8th-annual-c21-bioventures-the-lifescience-private-equity-conference/</loc>
		<lastmod>2006-02-17T14:30:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 117: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/venture-capital-executive-program/</loc>
		<lastmod>2006-02-17T13:36:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 116: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/neurotech-investing-and-business-conference/</loc>
		<lastmod>2006-02-17T06:55:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 115: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/calbio-06-californias-life-science-conference-and-annual-dinner/</loc>
		<lastmod>2006-02-17T06:55:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 114: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/first-annual-wtc-angel-investor-colloquium/</loc>
		<lastmod>2006-02-17T05:15:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 113: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/biotechnology-law-reporter/</loc>
		<lastmod>2006-02-17T01:22:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 112: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/allicense-2006/</loc>
		<lastmod>2006-02-10T14:14:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 111: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/global-life-science-innovation-competition/</loc>
		<lastmod>2006-02-02T13:06:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 110: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/non-vc-funding-of-biotech-startups-individual-investors-private-funds-and-investing-groups/</loc>
		<lastmod>2006-01-25T12:14:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 109: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/second-annual-wtc-venture-capital-awards/</loc>
		<lastmod>2006-01-21T05:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 108: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/from-the-laboratory-to-leadership/</loc>
		<lastmod>2006-01-20T06:43:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 107: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-march-breakfast-meeting/</loc>
		<lastmod>2006-01-19T01:38:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 106: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/third-annual-global-bioexecutive-program-module-three/</loc>
		<lastmod>2006-01-18T04:05:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 105: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/grow-your-revenues-without-venture-capital/</loc>
		<lastmod>2006-01-16T12:44:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 104: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/nanofabrication-what-can-self-assembly-do-for-nanotech-applications/</loc>
		<lastmod>2006-01-16T12:33:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 103: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/third-annual-global-bioexcutive-program-elective/</loc>
		<lastmod>2006-01-16T06:41:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 785: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/harlan-lunch-learn-polyclonal-antibody-production-2/</loc>
		<lastmod>2006-01-16T06:41:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 784: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/healthcarebio-science-summit-spring-venture-forum-new-frontiers-in-medicine-2/</loc>
		<lastmod>2006-01-16T06:41:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 102: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/harlan-lunch-learn-polyclonal-antibody-production/</loc>
		<lastmod>2006-01-16T06:41:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 99: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/specialty-pharmaceuticals-licensing-ip-strategies-for-faster-value-creation/</loc>
		<lastmod>2006-01-16T06:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 100: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/clinical-trials-essential-an-intensive-course/</loc>
		<lastmod>2006-01-16T06:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 783: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/specialty-pharmaceuticals-licensing-ip-strategies-for-faster-value-creation-2/</loc>
		<lastmod>2006-01-16T06:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 98: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-stem-cell-meeting/</loc>
		<lastmod>2006-01-16T06:40:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 782: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/molecular-bioproducts-vwr-and-nalge-nunce-bioproducts-lunch-learn-2/</loc>
		<lastmod>2006-01-16T06:40:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 97: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/molecular-bioproducts-vwr-and-nalge-nunce-bioproducts-lunch-learn/</loc>
		<lastmod>2006-01-16T06:40:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 96: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ispe-15th-annual-vendor-night/</loc>
		<lastmod>2006-01-16T06:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 95: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/asia-biotech-webinar/</loc>
		<lastmod>2006-01-16T06:00:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 94: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bios-intellectual-property-counsels-committee-spring-meeting/</loc>
		<lastmod>2006-01-16T05:53:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 93: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/california-life-sciences-day-at-the-state-capital/</loc>
		<lastmod>2006-01-16T05:53:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 92: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/californias-stem-cell-initiative-confronting-the-legal-and-policy-challenges/</loc>
		<lastmod>2006-01-16T05:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 91: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2nd-international-conference-on-stem-cell-research-and-therapeutics/</loc>
		<lastmod>2006-01-16T04:42:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 90: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/ceo-summit-2006-the-future-of-healthcare-innovations/</loc>
		<lastmod>2006-01-16T04:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 89: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/third-annual-global-bioexcutive-program-module-two/</loc>
		<lastmod>2006-01-16T04:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 88: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/dedication-ceremony-for-the-sdsu-bioscience-center/</loc>
		<lastmod>2006-01-14T01:11:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 86: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/calculating-and-proving-patent-damages/</loc>
		<lastmod>2005-12-19T04:33:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 85: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/dilemma-of-the-reasonable-royalty-rate/</loc>
		<lastmod>2005-12-11T09:46:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 82: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/power-tools-to-maximize-career-success-a-workshop-to-promote-professional-development-2/</loc>
		<lastmod>2005-12-02T05:35:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 81: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/ruling-on-suits-challenging-legality-of-california-stem-cell-institute/</loc>
		<lastmod>2005-12-01T08:52:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 80: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/licensing-executives-society/</loc>
		<lastmod>2005-11-29T05:34:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 79: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/bio/</loc>
		<lastmod>2005-11-29T05:18:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 78: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/baybio/</loc>
		<lastmod>2005-11-29T05:13:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 77: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/links-of-interest/biocom/</loc>
		<lastmod>2005-11-29T05:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 76: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/stem-cell-initiative-where-we-are-one-year-later/</loc>
		<lastmod>2005-11-28T01:41:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 75: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-role-of-marketing-in-the-bioscience-industry/</loc>
		<lastmod>2005-11-27T05:18:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 74: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-secrets-of-my-success-for-building-value/</loc>
		<lastmod>2005-11-27T04:56:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 73: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/corporate-ip-management-obligations-and-responsibilities-in-the-post-sox-world/</loc>
		<lastmod>2005-11-27T03:20:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 72: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/les-2006-winter-meeting/</loc>
		<lastmod>2005-11-27T03:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 71: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/usjapan-biobridge/</loc>
		<lastmod>2005-11-26T15:38:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 70: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-science-education-network-kickoff-meeting/</loc>
		<lastmod>2005-11-26T15:26:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 69: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/chis-13th-international-molecular-medicine-tri-conference/</loc>
		<lastmod>2005-11-26T04:51:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 68: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/third-annual-global-bioexcutive-program/</loc>
		<lastmod>2005-11-26T03:20:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 66: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/licenses-in-bankruptcy/</loc>
		<lastmod>2005-11-26T02:41:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 64: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-monthly-breakfast/</loc>
		<lastmod>2005-11-26T02:41:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 65: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/labautomation-2006/</loc>
		<lastmod>2005-11-26T02:41:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 63: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/power-tools-to-maximize-career-success-a-workshop-to-promote-professional-development/</loc>
		<lastmod>2005-11-25T12:10:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 62: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/genzyme-to-buy-san-diego-manufacturing-facility-of-cell-genesys/</loc>
		<lastmod>2005-11-25T03:04:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 60: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biomedical-product-development/</loc>
		<lastmod>2005-11-10T14:53:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 59: Comments: 2 of 34 = 0.1 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/theravance-to-collaborate-with-astellas-pharma-inc-to-commercialize-televancin/</loc>
		<lastmod>2005-11-09T15:29:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 58: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/pep-talk-conference/</loc>
		<lastmod>2005-11-09T15:04:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 57: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-legislative-developments/special-election/</loc>
		<lastmod>2005-11-09T09:55:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 56: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/novartis-purchases-emeryville-based-chiron/</loc>
		<lastmod>2005-11-02T12:14:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 55: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/year-end-wrap-up-state-of-the-industry/</loc>
		<lastmod>2005-11-02T02:45:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 53: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/new-frontiers-in-radiotherapy/</loc>
		<lastmod>2005-10-21T03:07:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 52: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/les-san-diegos-holiday-party/</loc>
		<lastmod>2005-10-17T04:53:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 51: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotechnology-roundtable-a-forum-for-business-professionals/</loc>
		<lastmod>2005-10-16T12:51:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 50: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-legislative-lunch-and-learn-preservation-of-industrial-land-with-marney-cox/</loc>
		<lastmod>2005-10-15T14:10:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 49: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/connect-most-innovative-product-awards-2005/</loc>
		<lastmod>2005-10-15T02:55:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 46: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/baybionests-holiday-soiree-2005/</loc>
		<lastmod>2005-10-15T02:34:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 44: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-december-breakfast-meeting/</loc>
		<lastmod>2005-10-11T13:11:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 43: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/accelerating-clinical-trials-with-biomarkers/</loc>
		<lastmod>2005-10-11T05:27:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 42: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/celebrating-a-decade-of-genome-sequencing/</loc>
		<lastmod>2005-10-10T14:31:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 39: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-disputes/alza-loses-battle-to-keep-generic-off-market/</loc>
		<lastmod>2005-09-30T16:29:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 781: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/venture-technology-conference-2005-2/</loc>
		<lastmod>2005-09-30T15:31:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 38: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/venture-technology-conference-2005/</loc>
		<lastmod>2005-09-30T15:31:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 37: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-patents/genentech-hit-with-adverse-patent-ruling/</loc>
		<lastmod>2005-09-30T08:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 35: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biocom-legislative-roundtable/</loc>
		<lastmod>2005-09-30T02:45:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 36: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/les-svcles-women-in-licensing-holiday-reception/</loc>
		<lastmod>2005-09-30T02:45:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 34: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/workitcoms-annual-silicon-valley-mixer/</loc>
		<lastmod>2005-09-30T02:36:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 33: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/international-licensing/</loc>
		<lastmod>2005-09-30T02:36:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 32: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/san-diego-biotech-discussion-group/</loc>
		<lastmod>2005-09-30T02:36:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 31: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/effective-licensing-compliance-programs-how-often-do-they-really-exist/</loc>
		<lastmod>2005-09-30T01:06:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 30: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-deals/insights-on-modern-biotech-dealmaking/</loc>
		<lastmod>2005-09-26T06:41:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 27: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/law-seminars-international-conference-running-the-race-with-biotechnology/</loc>
		<lastmod>2005-09-16T09:21:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 28: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/california-healthcare-policy-forum/</loc>
		<lastmod>2005-09-16T09:21:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 26: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/checkered-past-and-promising-future-of-antibody-therapeutics/</loc>
		<lastmod>2005-09-16T09:21:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 25: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotechnology-law-2005/</loc>
		<lastmod>2005-09-16T09:21:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 24: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/us-india-synergy-in-life-sciences/</loc>
		<lastmod>2005-09-16T09:21:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 23: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/the-baybio-pantheon-awards/</loc>
		<lastmod>2005-09-16T09:21:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 22: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotech-investing-conference/</loc>
		<lastmod>2005-09-16T09:05:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 21: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/patenting-of-life-forms/</loc>
		<lastmod>2005-09-16T02:29:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 20: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/trans-national-license-patenting/</loc>
		<lastmod>2005-09-16T02:29:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 19: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bionetwork-2005/</loc>
		<lastmod>2005-09-15T10:13:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 18: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioinvestor-forum-2005/</loc>
		<lastmod>2005-09-14T10:21:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 17: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/bioscience-forum/</loc>
		<lastmod>2005-09-14T09:48:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 16: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/regulatory-and-reimbursement-policy-roundtable/</loc>
		<lastmod>2005-09-14T09:48:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 780: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2005-baybionest-life-sciences-entrepreneur-investor-roundtables-2/</loc>
		<lastmod>2005-09-14T08:01:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 15: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/2005-baybionest-life-sciences-entrepreneur-investor-roundtables/</loc>
		<lastmod>2005-09-14T08:01:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 14: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/biotech-in-san-francisco-development-issues-and-opportunities/</loc>
		<lastmod>2005-09-14T05:46:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 13: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/stem-cell-research-charting-new-directions-for-california/</loc>
		<lastmod>2005-09-14T03:31:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 12: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/gene-acres-2005/</loc>
		<lastmod>2005-09-13T08:44:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 11: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/building-and-managing-patent-portfolios-in-the-life-sciences/</loc>
		<lastmod>2005-09-12T09:45:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/biotech-industry-events/latest-thinking-on-attackingdefending-patent-rights-in-the-us-pharmaceutical-and-biotechnology-markets/</loc>
		<lastmod>2005-09-11T09:58:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/subscribe/rss-2/</loc>
		<lastmod>2005-09-09T13:54:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/legal-info/disclaimer/</loc>
		<lastmod>2005-09-09T13:53:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/legal-info/privacy-policy/</loc>
		<lastmod>2005-09-09T13:53:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6: Comments: 0 of 34 = 0 points -->	<url>
		<loc>http://californiabiotechlaw.com/archives/about-us/the-prinz-law-office/</loc>
		<lastmod>2004-09-15T09:29:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: End Postings --><!-- Debug: Start Custom Pages --><!-- Debug: End Custom Pages --><!-- Debug: Start additional URLs --><!-- Debug: End additional URLs --></urlset>